Objectives: - Understand the role and mechanism of action of PBSerum recombinant enzymes (collagenase, lipase and lyase) and HMWHA in the management of fibrosis-related pathologies.
- Establish the possible causes of fibrosis development and scar tissue formation: diagnostic approach and treatment strategy based on PBSerum recombinant enzymes and HMWHA.
Introduction: The use of recombinant enzymes along with HMWHA in the treatment of diverse skin problems is generating an increasingly significant interest thanks to their differential advantages over other active principles. While HMWA has proven efficacy in the prevention and treatment of fibrosis, enzymes are very selective molecules that catalyze metabolic reactions, being specific for a substrate on which they act without damaging adjacent structures. This specificity reduces the possibility of having any complication or adverse effect and it is responsible for their high security and efficacy level.
Materials / method: - PBSerum recombinant enzymes (collagenase, lipase, lyase)
- High Molecular Weight Hyaluronic Acid
Results: HMWHA decreases the rate of the fibrosis in affected tissues, playing a key role in its prevention and treatment.
Recombinant enzymes have proven efficacy in the treatment of diverse skin pathologies: fat accumulation, cellulite, flaccidity, scars, fibrosis… The clinical practice has revealed that they degrade specifically the substrates that mainly cause them (collagenase removes atrophic collagen fibers that lead to flaccidity and fibrosis, lipase degrades TG inside the adipocyte reducing fat accumulation and lyase acts in synergy with the other enzymes as a vehicle to help their expansion)
Conclusion: The combination of PBSerum recombinant enzymes with HMWHA have shown very favorable and encouraging results that may change the approach in the way certain skin pathologies have been treated so far.
Divulgação de informações
Você recebeu algum patrocínio para sua pesquisa neste tema?
Não
Você recebeu algum tipo de honorário, pagamento ou outra forma de compensação por seu trabalho neste estudo?
Não
Você possui relação financeira com alguma entidade que possa competir com os medicamentos, materiais ou instrumentos abordados no seu estudo?
Não
Você detém ou pediu a registro de patente para algum dos instrumentos, medicamentos ou materiais abordados no seu estudo?
Não
Este trabalho não recebeu nenhum patrocínio direto ou indireto. O mesmo está sob a própria responsabilidade do seu autor.